Towards Healthcare
Intelligence Platform

Enterprise Intelligence for the Global Cell & Gene Therapy Ecosystem

Real-time insights for the global cell and gene therapy industry

Company Landscape Market Share

USD 49.56 Bn

Projected Market Size by 2035

0.2 Mn+

Patients Treated Globally

25000+

Active Pipeline Programs

500+

Global Manufacturing Facilities

Company Landscape Market Share
8 K+
Discovery Assets in
early research
278.0% of pipeline
Company Landscape Market Share
1.5 K+
Preclinical
Trials
50.4% of pipeline
Company Landscape Market Share
55
Regulatory
Review
1.74% of pipeline
Company Landscape Market Share
650
Manufacturing
48% of pipeline
Company Landscape Market Share
0.2M
Commercialization
Patient treated
310 CDMOs
Company Landscape Market Share
1,567
Clinical
Trials
50+ countries
Platform Intelligence Modules

Nine analytics engines. One connected data layer.

MODULE 01

Commercial Intelligence

Treatment penetration and list-price trends tracked across five global regions.

39 Avg. Penetration
9 month A2P Time
68 Countries Live
35% Outcomes Pricing
Vector Capacity Mix
Vector Capacity Mix
Market Penetration by Region
Market Penetration by Region
MODULE 02

Epidemiological Trends

Prevalence, incidence and eligible patient modelling across 60+ CGT indications in 30+ countries.

205,828 Patient Treated
50 Disease indication
90% Forecast Accuracy
17.7M Eligible Population
Global Cell & Gene Therapy Market Distribution by Therapeutic Area
Vector Capacity Mix
Epidemiology & Market Opportunity
Market Penetration by Region
MODULE 03

Pipeline Analysis

3,157 pipeline assets supported by 8,776 discovery programs.

3,157 Total Assets
8,776 Discovery
1,567 Clinical
105 Approved
Development funnel
Development Funnel
Therapeutic Platform
Therapeutic Platform
MODULE 04

Clinical Trial Landscape

70%+ of CGT programs are in clinical development.

1,567 Clinical Trial
30 Sponsors
680 Countries
199,250 Enrollment
Geographic Distribution
Geographic Distribution
Gene Therapy Clinical Trial Trends
Gene Therapy Clinical Trial Trends
MODULE 05

Manufacturing Intelligence

518 facilities and 310 CDMOs across 42 countries.

650 Manufacturing
34 CDMOs
185+ GMP
35+ Countries
Facility Type
Facility Type
Manufacturing Type
Manufacturing Type
MODULE 06

Regulatory Scenario

105 approved Cell & Gene Therapy products tracked across FDA, EMA, PMDA, and NMPA.

105 Approvals
64 Fast Track
72 Orphan
31 RMAT
Regulatory Approval Distribution by Agency
Regulatory Approval Distribution by Agency
Annual CGT Product Approvals
Annual CGT Product Approvals
MODULE 07

Competitive Landscape

Benchmark CGT companies by pipeline strength, portfolio, and strategic positioning.

80 Companies
52 Biotech
18% Pharma
11% CDMO
Epidemiology & Market Opportunity
Epidemiology and Market Opportunity
Company Landscape – Market Share
Company Landscape Market Share
MODULE 08

Investment & Financing

Cell & gene therapy investment hit ~$8.9B in 2025.

8.9B Financial Insights
88 (2025) VC Deal Count
15+ M&A
10+ Partnerships
Company Landscape – Market Share
Company Landscape Market Share
Global CGT Investment
Global CGT Investment

Discover the Leading Cell & Gene Therapy Intelligence Platform

Unlock exclusive cell and gene therapy insights, personalized demos, and tailored data solutions today.

Please select country!
Please enter phone number!
6512
Invalid Captcha!
Meet Our Experts

Analysts behind the data.

A global bench of life-sciences consultants validating every model and forecast.

Payal Rabde

Payal Rabde

Senior Healthcare Research Analyst

6+ Years Experience
Cell & Gene Therapy Oncology Intelligence Competitive Benchmarking Market Forecasting Pipeline Analytics
220+ PROJECTS
180+ REPORTS
220+ COUNTRIES
98% SATISFACTION
Vidheshwar

Vidheshwar

Lead Life Sciences Research Consultant

7+ Years Experience
Clinical Intelligence Regulatory Strategy Epidemiology Biotechnology Healthcare Analytics
260+ PROJECTS
140+ CLIENTS
96% ACCURACY
32 TA AREAS
Shekhar

Shekhar

Business Intelligence Director

10+ Years Experience
Commercial Intelligence Healthcare Strategy Enterprise Solutions Business Development Market Analytics
350+ PROJECTS
210+ CLIENTS
50+ COUNTRIES
12 YEARS
Get Started

Ready to Unlock the Future of Cell & Gene Therapy Intelligence?

Empower your strategic decisions with one of the industry's most comprehensive intelligence platforms, delivering real-time insights into pipelines, clinical trials, regulatory developments, manufacturing capacity, market forecasts, competitive landscapes, and investment activity — all through a single interactive experience.

Company Landscape Market Share

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.